Ann: Half year results, management changes and guidance, page-29

First 29 Last

Share
Profile

Follow
ralom

10,715 Posts.

108

02/03/19

11:43

Post #: 37629621
Share

Originally posted by Rep_001 ↑

That’s not a particularly informed comment if you understand how a FASA Facilities and Adminstration Services Agreement actually works in a Dental Practice. The reality is that Smiles has just a $1m in the bank and working capital facility that’s under threat. If they can’t be cashflow positive it’s over. Right now there’s a high likelihood that anyone supplying them is going to want cash upfront in case they do go into administration.

The dentists might get their revenue first for a procedure but if Smiles has no cash they can’t pay the receptionist to answer the phones or make bookings, can’t pay the nurse to assist the dentist and sterilise the instruments, can’t pay the practice manager to order product and manage staff and rosters, can’t pay the suppliers for dental products and consumables or crowns, can’t pay the rent on the premises, can’t pay the IT and comms charges to have practice management systems to record, send out recalls via SMS and email or the HiCaps terminal fees to bill the Medical Funds then it is going to grind to a halt awfully quickly.

SIL is no position to buy back anyone’s phantom equity (let’s be clear it’s not actually part ownership at all, it’s a right to a share of earnings there’s not title or charge over practice assets to the vendor) and there is no one who’s going to buy the existing phantom equity off the vendors with such uncertainty about SIL as a going concern.

If they do get a waiver on the covenant with the bank, the bank will be protecting their interest only. And if it tips then those phantom equity profit shares are toast - any buyer talking to a receiver would be wanting to grab the practice, secure the patient list and then in all likelihood be in a box seat to dictate terms to the clinicians.

Expand

I can’t remember but can you tell me if was a combination of shares and cash offered to practionners when they “ sold” in ?

Perhaps practionners can “buy” back the share of their practice they sold for a pittance ?

Never liked the model when introduced

SIL Price at posting: 13.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

There are more pages in this discussion • 19 more messages in this thread...

First 29 Last

Add SIL (ASX) to my watchlist

Ann: Half year results, management changes and guidance, page-29

Top Stories

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Sales growth pushes Lovisa's fortunes (and shares) upwards

Scientific conference spotlights PYC's work on blindness disease treatment